Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 15, 2019
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trialNorihiro Kogame, Ply Chichareon, Kenneth De Wilder, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 11, 2020
Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarctionHideyuki Kawashima, Hironori Hara, Rutao Wang, et al.
Atherosclerosis|May 26, 2020
The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trialRutao Wang, Kuniaki Takahashi, Ply Chichareon, et al.
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
Nature Reviews. Cardiology|January 19, 2020
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseDavide Capodanno, Deepak L Bhatt, John W Eikelboom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 4, 2023
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)Eliano Pio Navarese, Antonio Landi, Angelo Oliva, et al.
Journal of the American College of Cardiology|January 29, 2021
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary SyndromesSergio Leonardi, Felice Gragnano, Greta Carrara, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic diseaseMarco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
European Heart Journal|January 29, 2019
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trialMartina Rothenbühler, Marco Valgimigli, Ayodele Odutayo, et al.
Circulation|July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeMarco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 15, 2019
Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trialNorihiro Kogame, Ply Chichareon, Kenneth De Wilder, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 11, 2020
Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarctionHideyuki Kawashima, Hironori Hara, Rutao Wang, et al.
Atherosclerosis|May 26, 2020
The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trialRutao Wang, Kuniaki Takahashi, Ply Chichareon, et al.
International Journal of Cardiology|August 5, 2020
Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trialKuniaki Takahashi, Rutao Wang, Hideyuki Kawashima, et al.
Nature Reviews. Cardiology|January 19, 2020
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseDavide Capodanno, Deepak L Bhatt, John W Eikelboom, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 4, 2023
Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)Eliano Pio Navarese, Antonio Landi, Angelo Oliva, et al.
Journal of the American College of Cardiology|January 29, 2021
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary SyndromesSergio Leonardi, Felice Gragnano, Greta Carrara, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2023
Antithrombotic treatment strategies in patients with established coronary atherosclerotic diseaseMarco Valgimigli, Victor Aboyans, Dominick Angiolillo, et al.
European Heart Journal|January 29, 2019
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trialMartina Rothenbühler, Marco Valgimigli, Ayodele Odutayo, et al.
Circulation|July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeMarco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Pageof 31